Card-20(22)-enolide,3-[(O-b-D-glucopyranosyl-(1®4)-O-3-O-acetyl-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxy-,(3b,5b,16b)- cas no:17575-21-2

NameCard-20(22)-enolide,3-[(O-b-D-glucopyranosyl-(1®4)-O-3-O-acetyl-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxy-,(3b,5b,16b)-
CAS17575-21-2
Synonyms5b-Card-20(22)-enolide, 3b-[[O-[O-(O-glucosyldigitoxosyl)digitoxosyl]digitoxosyl]oxy]-14,16b-dihydroxy-, acetate (7CI);Lanatoside B (6CI,8CI); Digilanide B; NSC 7535
EINECS(EC#)241-545-6
Molecular FormulaC49H76 O20
Molecular Weight985.10

refractive index1.608

Safety

Poison by intravenous route. When heated to decomposition it emits acrid smoke and irritating fumes.

1.		ivn-rat LDLo:12 mg/kg		AEPPAE    Naunyn-Schmiedeberg’s Archiv fuer Experimentelle Pathologie und Pharmakologie. 177 (1934),60.
2.		ivn-cat LD50:388 µg/kg		JAPMA8    Journal of the American Pharmaceutical Association, Scientific Edition. 31 (1942),236.
3.		ivn-gpg LDLo:3695 µg/kg		AEPPAE    Naunyn-Schmiedeberg’s Archiv fuer Experimentelle Pathologie und Pharmakologie. 252 (1966),314.